13F filer · CIK 1422849 ↗
Capital World Investors
You are looking at Q3 2022. See the latest, Q2 2026 →
Reported value
$445.41B
−5.4% on the quarter before
Positions
549
24 new · 38 sold out
Top 10
29.0%
of the value
Est. gain
−$18.97B
on stocks held all quarter
Est. return
−4.3%
on those stocks since Q2 2022
Positions as of Sep 30, 2022, from Capital World Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 43% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2022. Striped tiles are options.
Largest buys
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Extra Space Storage Inc~$1.32BAdded · 0.1% → 0.4%+7,642,366 shares
- Synopsys~$1.16BNew · 0.0% → 0.3%+3,811,523 shares
- Dollar Tree Inc~$1.03BAdded · 0.3% → 0.5%+7,602,775 shares
- Lennar Corp~$1.03BAdded · 0.0% → 0.3%+13,868,053 shares
- Morgan Stanley~$891.8MAdded · 0.1% → 0.3%+11,287,013 shares
- Jacobs Solutions Inc~$826.0MNew · 0.0% → 0.2%+7,613,274 shares
- Alnylam Pharmaceuticals Inc~$732.3MAdded · 0.3% → 0.6%+3,658,635 shares
- Conocophillips~$707.5MAdded · 0.5% → 0.8%+6,912,860 shares
- Linde Plc~$623.2MAdded · 0.6% → 0.7%+2,309,458 shares
- Discover Finl Svcs~$558.0MAdded · 0.2% → 0.4%+6,137,403 shares
Largest sells
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Micron~$1.13BCut · 0.4% → 0.2%−22,567,287 shares
- Jacobs Solutions~$982.6MSold out · 0.2% → 0.0%−7,729,385 shares
- Broadcom~$923.6MSold out · 0.2% → 0.0%−614,437 shares
- Meta~$816.3MCut · 1.3% → 1.0%−6,016,567 shares
- Dollar Gen Corp New~$716.6MCut · 0.7% → 0.5%−2,987,676 shares
- Stellantis N.V~$697.7MCut · 0.2% → 0.1%−59,046,867 shares
- S&P Global Inc~$619.7MCut · 0.4% → 0.3%−2,029,609 shares
- Regency Ctrs Corp~$613.3MCut · 0.2% → 0.1%−11,389,672 shares
- AT&T~$601.4MCut · 0.3% → 0.1%−39,206,166 shares
- Adobe~$527.3MCut · 0.2% → 0.0%−1,915,041 shares
Holdings
As of Sep 30, 2022. Changes are in shares against Jun 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TeslaCOM · shares −0.4% · price +18.2% | 5.4% | $23.92B | +$3.68B | ||||||||
| MicrosoftCOM · shares −1.3% · price −9.3% | 5.1% | $22.72B | −$2.33B | ||||||||
| Unitedhealth Group IncCOM · shares −2.6% · price −1.7% | 3.8% | $16.78B | −$285.3M | ||||||||
| BroadcomCOM · shares −0.03% · price −8.6% | 3.2% | $14.04B | −$1.32B | ||||||||
| Home Depot IncCOM · shares −0.8% · price +0.6% | 2.5% | $11.05B | +$67.1M | ||||||||
| Pfizer IncCOM · shares −0.5% · price −16.5% | 2.4% | $10.89B | −$2.16B | ||||||||
| Eli LillyCOM · shares +1.0% · price −0.3% | 2.1% | $9.39B | −$25.1M | ||||||||
| Philip Morris Intl IncCOM · shares +2.2% · price −15.9% | 1.6% | $7.05B | −$1.31B | ||||||||
| Thermo Fisher Scientific IncCOM · shares −3.6% · price −6.6% | 1.5% | $6.84B | −$486.6M | ||||||||
| Canadian Nat Res LtdCOM · shares +0.1% · price −13.4% | 1.5% | $6.52B | −$1.00B | ||||||||
| Cvs Health CorpCOM · shares +3.5% · price +2.9% | 1.3% | $5.81B | +$159.5M | ||||||||
| AlphabetCAP STK CL C · shares −0.7% · price −16.5% | 1.3% | $5.73B | −$1.13B | ||||||||
| Cme Group IncCOM · shares −5.6% · price −13.5% | 1.2% | $5.53B | −$860.9M | ||||||||
| Lockheed Martin CorpCOM · shares −9.0% · price −10.2% | 1.1% | $4.78B | −$540.2M | ||||||||
| Caterpillar IncCOM · shares +7.1% · price −8.2% | 1.1% | $4.77B | −$398.3M | ||||||||
| MetaCL A · shares −16% · price −15.9% | 0.99% | $4.39B | −$827.7M | ||||||||
| Regeneron PharmaceuticalsCOM · shares −0.1% · price +16.5% | 0.96% | $4.29B | +$608.5M | ||||||||
| Pioneer Nat Res CoCOM · shares +8.3% · price −2.9% | 0.93% | $4.14B | −$115.8M | ||||||||
| AppleCOM · shares +0.6% · price +1.1% | 0.92% | $4.11B | +$44.0M | ||||||||
| Jpmorgan Chase & CoCOM · shares −0.7% · price −7.2% | 0.91% | $4.07B | −$316.3M | ||||||||
| AlphabetCAP STK CL A · shares +2.2% · price −16.6% | 0.85% | $3.80B | −$740.5M | ||||||||
| Centene Corp DelCOM · shares +2.4% · price −8.0% | 0.85% | $3.79B | −$323.2M | ||||||||
| Vertex Pharmaceuticals IncCOM · shares −0.4% · price +2.8% | 0.81% | $3.63B | +$97.1M | ||||||||
| Gilead Sciences IncCOM · shares +9.3% · price −0.2% | 0.80% | $3.56B | −$6.3M | ||||||||
| Archer Daniels Midland CoCOM · shares +0.2% · price +3.7% | 0.76% | $3.38B | +$119.6M | ||||||||
| Total · 549 positions | 100% | $445.41B | −$18.97B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2022 to Q3 2022: 519 stocks held throughout, down $18.97B (−4.3%).
- Tesla3:1 split+$3.68B+18%
- Netflix+$706.4M+35%
- Regeneron Pharmaceuticals+$608.5M+17%
- Alnylam Pharmaceuticals Inc+$559.0M+37%
- Conocophillips+$325.9M+14%
- Alphabet19:1 split−$1.13B−16%
- Philip Morris Intl Inc−$1.31B−16%
- Broadcom−$1.32B−9%
- Pfizer Inc−$2.16B−17%
- Microsoft−$2.33B−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 4 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $846.43B+15% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $732.94B−0% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $735.30B+0% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $732.04B+6% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $687.95B+11% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $617.20B−6% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $658.71B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $645.05B+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $613.27B+1% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $604.23B+7% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $562.26B+11% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $504.81B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $519.91B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $483.79B+3% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $469.11B+5% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $445.41B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $470.72B−19% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $580.76B−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $632.21B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $585.85B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $588.43B+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $541.07B+4% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $518.94B+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $456.91B+11% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $413.27B+20% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $344.62B−23% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $447.39B+8% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $415.21B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $426.29B+3% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $412.39B+12% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $369.11B−10% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $411.05B−12% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $467.29B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $444.21B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $461.25B+4% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $441.49B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $425.76B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $418.31B+5% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $397.60B+3% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $384.55B+4% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $370.85B+2% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $361.93B | SEC ↗ |